Effect of lazaroid U-74389G and methylprednisolone on endotoxin-induced shock in mice

Surgery

Volumn 125, Issue 4, 1999, Pages 421-430

  Fukuma, Kazuyuki ^a,b,c   Marubayashi, Seiji ^a,b,c   Okada, Kazuro ^a,b,c   Yamada, Kazuo ^a,b,c   Kimura, Akinori ^a,b,c   Dohi, Kiyohiko ^a,b,c  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; CORTICOSTEROID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAZAROID; MESSENGER RNA; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; ENDOTOXEMIA; GENE EXPRESSION REGULATION; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0032919644     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(99)70010-3     Document Type: Article

References (55)

1. 1. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;317:653-8.
2. 2. Veterans Administration Systemic Sepsis Cooperative Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987;317:659-65.
3. 3. Dhainaut JF, Tenaillon A, LeTulzo Y, Schlemmer B, Solet JP, Wolf M, et al. Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-contolled, multicenter clinical trial. Crit Care Med 1994;22:1720-8.
4. 4. Fisher CJ, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slouman GJ, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. JAMA 1994;271:1836-43.
5. 5. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial. JAMA 1995:273:934-41.
6. 6. Maeda T, Marubayashi S, Fukuma K, Sugino K, Yamada K, Dohi K. Effect of antileukocyte adhesion molecule antibodies, nitric oxide synthase inhibitor, and corticosteroids on endotoxin shock in mice. Surg Today 1997;27:22-9.
7. 7. Knowles RG, Salter M, Brooks SL, Moncada S. Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem Biophys Res Commun 1990;172:1042-8.
8. 8. Braughler JM, Pregenzer JF, Chase RL, Duncan LA, Jacobsen EJ, McCall JM. Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 1987;262:10438-40.
9. 9. Braughler JM, Chase RL, Neff GL, Yonkers PA, Day JS, Hall HD, et al. A new 21-aminosteroid antioxidant lacking glucocorticoid activity stimulates adrenocorticotropin secretion and blocks arachidonic acid release from mouse pituitary tumor (AtT-20) cells. J Pharmacol Exp Ther 1988;244:423-7.
10. + pump ATPase of human red blood cell membranes. Biochem Pharmacol 1993:46:525-34.
11. 11. Wang Y, Mathews WR, Guido DM, Jaeschke H. The 21-aminosteroid tirilazad mesylate protects against liver injury via membrane stabilization not inhibition of lipid peroxidation. J Pharmacol Exp Ther 1996;277:714-20.
12. 12. Currin RT, Reinstein LJ, Lichtman SN, Thurman RG, Lemasters JJ. Inhibition of tumor necrosis factor release from cultured rat Kupffer cells by agents that reduce graft failure from storage injury. Transplant Proc 1993;25:1631-2.
13. 13. Semrad SD, Rose ML, Adams JL. Effect of tirilazad mesylate (U74006F) on eicosanoid and tumor necrosis factor generation in healthy and endotoxemic neonatal calves. Circ Shock 1993;40:235-42.
14. 14. Zhang H, Spapen H, Manikis P, Rogiers P, Metz G, Buurman WA, et al. Tirilazad mesylate (U-74006F) inhibits effects of endotoxin in dogs. Am J Physiol 1995;268:111847-55.
15. 15. Shenkar R, Abraham E. Effects of treatment with 21-aminosteroid, U74389F, on pulmonary cytokine expression following hemorrhage and resuscitation. Crit Care Med 1995;23: 132-9.
16. 16. Krysztopik RJ, Bentley FR, Spain DA, Wilson MA, Garrison RN. Free radical scavenging by lazaroids improved renal blood flow during sepsis. Surgery 1996;120:657-62.
17. 17. Krysztopik RJ, Bentley FR, Spain DA, Wilson MA, Garrison RN. Lazaroids improve intestinal blood flow in the rat during hyperdynamic bacteraemia. Br J Surg 1997;84:1717-21.
18. 18. Johnson D, Hurst T, Prasad K, Wilson T, Saxena A, Murphy F, et al. Lazaroid pretreatment preserves gas exchange in endotoxin-treated dogs. J Crit Care 1994;9:213-33.
19. 19. Remmers D, Dwenger A, Grotz M, Seekamp A, Pape HC, Gruner A, et al. Attenuation of multiple organ dysfunction in a chronic sheep model by the 21-aminosteroid U74389G. J Surg Res 1996;62:278-83.
20. 20. Baeuerte PA, Henkel T. Function and activation of NF-kB in the immune system. Annu Rev Immunol 1994;12:141-79.
21. 21. Suzuki YJ, Mizuno M, Packer L. Signal transduction for nuclear factor-kB activation. J Immunol 1994;153:5008-15.
22. 22. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J 1991;10:2247-58.
23. 23. Pinkus R, Weiner LM, Daniel V. Role of oxidants and antioxidants in the induction of AP-I, NF-kB, and glutathione S-transferase gene expression. J Biol Chem 1996;271:13422-9.
24. 24. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 1995;270: 283-6.
25. 25. Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, Jongeneel CV. kB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J Exp Med 1990;171:34-47.
26. 26. Xie Q Kashiwabara Y, Nathan C. Role of transcription factor NF-kB/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-8.
27. 27. Sugino K, Dohi K, Yamada K, Kawasaki T. The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants. Surgery 1987;101:746-52.
28. 28. Sugino K, Dohi K, Yamada K, Kawasaki T. Changes in the levels of endogenous antioxidants in the liver of mice with experimental endotoxemia and the protective effects of the antioxidants. Surgery 1989;105:200-6.
29. 29. Masngi F, Nakamura T. Effect of vitamin E deficiency on the level of superoxide dismutase, glulathione peroxidase, catalase, and lipid peroxide in rat liver. Int J Vitam Nutr Res 1976;46:187-91.
30. 10. Surgery 1982;91:631-7.
31. 31. Marubayashi S, Dohi K, Ochi K, Kawasaki T. Role of free radicals in ischemic rat liver cell injury: prevention of damage by α-tocopherol administration. Surgery 1986;99:184-91.
32. 32. Kawasaki T, Marubayashi S. Liver in shock. In: Barett JM, Nyhus LM, editors. Treatment of shock. 2nd ed. Philadelphia: Lea & Febiger; 1986. p 151-62.
33. 33. Marubayashi S, Dohi K, Sugino K, Kawasaki T. The protective effect of administered α-tocopherol against hepatic damage caused by ischemia-reperfusion or endotoxemia. Ann NY Acad Sci 1989;570:208-18.
34. 15N] nitrate in biological fluids. Anal Biochem 1982;126:131-8.
35. 35. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
36. 36. Dignam JD, Lebowitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983;11:1475-89.
37. 37. Lenardo MJ, Baltimore D. NF-kB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989;58:227-9.
38. 38. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1989.
39. 39. Marubayashi S, Oshiro Y, Fukuma K, Okada K, Hinoi T, Ikeda M, et al. Protective effect of monoclonal antibodies to adhesion molecules on rat liver ischemia-reperfusion injury. Surgery 1997;122:45-52.
40. 40. Slater TF. Free-radical mechanisms in tissue injury. Biochem J 1984;222:1-15.
41. 41. Lepage G, Munoz G, Champagne J, Roy CC. Preparative steps necessary for the accurate measurement of malondialdehyde by high-performance liquid chromatography. Anal Biochem 1991;197:277-83.
42. 42. Schlayer HJ, Laaff H, Peters T, Woort-Menker M, Estler HC, Karck U, et al. Involvement of tumor necrosis factor in endotoxin-triggered neutrophil adherence to sinusoidal endothelial cells of mouse liver and its modulation in acute phase. J Hepatol 1988;7:239-49.
43. 43. Jaeschke H, Farhood A, Smith CW. Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol 1991;261:G1051-6.
44. 44. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ. Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am J Physiol 1993;264:G801-9.
45. 45. Suzuki S, Toledo-Pereyra LH. Monoclonal antibody to intercellular adhesion molecule 1 as an effective protection for liver ischemia and reperfusion injury. Transplant Proc 1994;26:325-7.
46. 46. Essani NA, Fisher MA, Farhood A, Manning AM, Smith CW, Jaeschke H. Cytokine-induced hepatic intercellular adhesion molecule-1 (ICAM-1) mRNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure. Hepatology 1995;21:1632-9.
47. 47. Rubbo H, Radi R, Trujillo M, Telleri R. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. J Biol Chem 1994;264:26066-75.
48. 48. Beckman JS, Beckman TW, Chen J, Marshal PA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990;87:1620-4.
49. 49. Collins T, Read MA, Neish AS, Whitly MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kB and cytokine-inducible enhancers. FASEB J 1995;9:899-909.
50. 50. Thanos D, Maniatis T. NF-kB: a lesson in family values. Cell 1995;80:529-32.
51. 51. Essani NA, McGuire GM, Manning AM, Jaeschke H. Endotoxin-induced activation of the nuclear transcription factor kB and expression of E-selectin messenger RNA in hepatocytes, Kupffer cells, and endothelial cells in vivo. J Immunol 1996;156:2956-63.
52. 52. Essani NA, Fisher MA, Jaeschke H. Inhibition of NF-kB activation by dimethyl sulfoxide correlates with suppression of TNF-α formation, reduced ICAM-1 gene transcription, and protection against endotoxin-induced liver injury. Shock 1997;7:90-6.
53. 53. Lehmann CH, Egerer K, Georgiew A, Weber M, Kox WJ. Inhibition of tumor necrosis factor-α release in rat experimental endotoxemia by treatment with the 21-aminosteroid U-74389G [abstract]. Intensive Care Med 1996;22(3 Suppl):S338.
54. 54. Fink MP, Heard SO. Laboratory models of sepsis and septic shock. J Surg Res 1990;49:186-96.
55. 55. Powell RJ, Machiedo GW, Rush BF Jr, Dikdan GS. Effect of oxygen-free radical scavengers on survival in sepsis. Am Surg 1991;57:86-8.